QuidelOrtho Corp·4

Feb 10, 4:09 PM ET

Busky Joseph M. 4

Research Summary

AI-generated summary

Updated

QuidelOrtho CFO Joseph Busky Receives RSUs, Sells 1,806 Shares

What Happened Joseph M. Busky, Chief Financial Officer of QuidelOrtho Corporation (QDEL), had 5,968 restricted stock units (RSUs) release and convert into common shares on February 8, 2026. Those converted RSUs were issued at $0 (vesting/conversion). To satisfy tax withholding on the issuance, 1,806 of the shares were withheld/sold at $29.10 per share, generating proceeds of $52,555. The underlying RSUs were reported as exercised/converted (derivative transaction) and as an award/acquisition upon vesting.

Key Details

  • Transaction date: February 8, 2026 (filed Feb 10, 2026).
  • Shares issued on vesting: 5,968 RSUs converted to 5,968 common shares (acquired at $0).
  • Shares withheld/sold for taxes: 1,806 shares at $29.10, proceeds $52,555.
  • Footnotes: RSU release previously reported; withholding was used to satisfy tax obligations; 1 RSU = 1 share.
  • Vesting schedule: 5,968 shares vested on Feb 8, 2025 and 5,968 on Feb 8, 2026; remaining 5,969 RSUs vest on Feb 8, 2027.
  • Shares owned after transaction: Not specified in the provided excerpt.
  • Filing timeliness: No late filing indicated in the provided data.

Context This was a standard RSU vesting and tax-withholding transaction (common for executives). The conversion of RSUs to shares followed by share withholding to cover taxes is routine and does not by itself indicate a discretionary open-market sale or buy decision.